# Immunogenicity of Three HIV GTU® MultiHIV DNA Immunisations Administered Via Intramuscular, Intradermal and Transcutaneous Routes

> **NCT02075983** · PHASE1 · UNKNOWN · sponsor: **Imperial College London** · enrollment: 30 (estimated)

## Conditions studied

- HIV

## Interventions

- **BIOLOGICAL:** GTU®-multiHIV B clade

## Key facts

- **NCT ID:** NCT02075983
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-06
- **Primary completion:** 2015-06
- **Final completion:** 2015-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2014-03-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02075983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02075983, "Immunogenicity of Three HIV GTU® MultiHIV DNA Immunisations Administered Via Intramuscular, Intradermal and Transcutaneous Routes". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02075983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*